MetLife Investment Management’s Sana Biotechnology SANA Stock Holding History

MetLife Investment Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384K	Buy	109,959 +43,408	+65%	+$140K	﹤0.01%	2072
2026 Q1	$192K	Sell	66,551 -26,575	-29%	-$105K	﹤0.01%	2252
2025 Q4	$379K	Buy	93,126 +14,120	+18%	+$63.2K	﹤0.01%	1925
2025 Q3	$280K	Sell	79,006 -2,499	-3%	-$9.04K	﹤0.01%	2122
2025 Q2	$223K	Buy	81,505 +639	+0.8%	+$1.32K	﹤0.01%	2134
2025 Q1	$136K	Buy	80,866 +53,208	+192%	+$149K	﹤0.01%	2386
2024 Q4	$45.1K	Sell	27,658 -49,952	-64%	-$149K	﹤0.01%	2748
2024 Q3	$323K	Hold	77,610	–	–	﹤0.01%	2019
2024 Q2	$424K	Buy	77,610 +29,289	+61%	+$233K	﹤0.01%	1815
2024 Q1	$483K	Hold	48,321	–	–	﹤0.01%	1695
2023 Q4	$197K	Hold	48,321	–	–	﹤0.01%	2256
2023 Q3	$187K	Hold	48,321	–	–	﹤0.01%	2254
2023 Q2	$288K	Hold	48,321	–	–	﹤0.01%	2041
2023 Q1	$158K	Hold	48,321	–	–	﹤0.01%	2358
2022 Q4	$191K	Hold	48,321	–	–	﹤0.01%	2275
2022 Q3	$290K	Hold	48,321	–	–	﹤0.01%	2048
2022 Q2	$311K	Hold	48,321	–	–	﹤0.01%	1994
2022 Q1	$399K	Buy	48,321 +17,543	+57%	+$142K	﹤0.01%	1920
2021 Q4	$476K	Hold	30,778	–	–	﹤0.01%	1532
2021 Q3	$693K	Buy	30,778 +19,193	+166%	+$403K	0.01%	1337
2021 Q2	$228K	Buy	+11,585	New	+$263K	﹤0.01%	2082

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

MetLife Investment Management's SANA Position: Q2 2026 in Review

MetLife Investment Management increased its Sana Biotechnology (SANA) stake by 65% in Q2 2026, buying an estimated $140K and bringing the position to 109,959 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #2072.

MetLife Investment Management first reported a position in SANA in Q2 2021 and has held it in 21 quarters since. The position peaked at $693K in Q3 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

MetLife Investment Management held 109,959 shares of Sana Biotechnology worth $384K as of Q2 2026.
MetLife Investment Management bought 43,408 Sana Biotechnology shares in Q2 2026, an estimated $140K.
Sana Biotechnology made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2072 holding.
MetLife Investment Management first reported a position in Sana Biotechnology in Q2 2021 and has held it in 21 quarters since.
MetLife Investment Management's Sana Biotechnology position peaked at $693K in Q3 2021.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.